title: [Supracricoid partial laryngectomy for the treatment of laryngeal cancer].
abstract: OBJECTIVE
  To evaluate the oncological and functional outcomes in patients undergoing supracricoid partial laryngectomy (SCPL).
  
  
  METHODS
  Forty-three cases underwent supracricoid partial laryngectomy with functional reconstruction in stage T1b-T4. In these cases, 16 were supraglottic cancers, 21 were glottic cancers, and 2 were subglottic cancers. Three types of supracricoid partial laryngectomy (cricohyoidopexy CHP, cricohyoidoepiglottopexy CHEP and tracheocricohyoidoepiglottopexy TCHEP) were employed accordingly.
  
  
  RESULTS
  The 3- and 5-year accumulative survival rates were 90.7% and 83.7% respectively (Kaplan-Meier method). Median follow-up time was 57 months. Decannulation rate was 95.3% (41/43) in those. The mean time of decannulation was 14 days in patients preserved both cricoarytenoid units and 43 days in those only preserved one cricoarytenoid unit. The removal of epiglottis increased the risk of aspiration and prolonged time of decannulation (P < 0.05).
  
  
  CONCLUSIONS
  Supracricoid partial laryngectomy for selected laryngeal cancer is feasible. The patients can gain satisfied survival rate and quality of life.
authors.affiliation: Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China.
authors.forename: Ping-zhang
authors.initials: PZ
authors.lastname: Tang
authors.forename: Ping-zhang
authors.initials: PZ
authors.lastname: Tang
authors.forename: Yong-fa
authors.initials: YF
authors.lastname: Qi
authors.forename: Zhen-gang
authors.initials: ZG
authors.lastname: Xu
authors.forename: Yao-huang
authors.initials: YH
authors.lastname: Wu
mesh_terms: D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000601:surgery*; D003413:Cricoid Cartilage / Q000601:surgery*; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000401:mortality / Q000601:surgery*; D007825:Laryngectomy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome